<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00601042</url>
  </required_header>
  <id_info>
    <org_study_id>SM 07-01</org_study_id>
    <secondary_id>SM 07-01</secondary_id>
    <nct_id>NCT00601042</nct_id>
  </id_info>
  <brief_title>Serbian Smoking Reduction/Cessation Trial (2SRT)</brief_title>
  <acronym>2SRT</acronym>
  <official_title>Randomized, Placebo-controlled, Double-blind, Phase IV Trial to Assess the Efficacy of a Traditional Swedish Smokeless Tobacco Product (&quot;Snus&quot;) to Reduce or Replace Cigarette Smoking Among Adult Smokers in Serbia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Swedish Match AB</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Swedish Match AB</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to establish if a low-nitrosamine, smokeless tobacco product (Swedish snus)
      can help adult smokers to reduce and eventually completely quit smoking.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Smoking reduction defined as a reduction in self-reported number of smoked cigarettes per day &gt;50% compared to base-line, verified by a reduction in CO in exhaled air of &gt;1 ppm compared to base-line</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Smoking cessation defined as self-reported total abstention from cigarettes verified by CO in exhaled air &lt;10 ppm</measure>
    <time_frame>3, 6, 9 and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical tests and biomarkers relevant for exposure to tobacco</measure>
    <time_frame>3, 6, 9, and 12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking reduction</measure>
    <time_frame>12, 24, 36 and 48 months</time_frame>
    <description>Smoking reduction according to self-report</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Smoking reduction</measure>
    <time_frame>12, 24, 36 and 48 months</time_frame>
    <description>Smoking reduction compared to baseline according to self-report</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">319</enrollment>
  <condition>Cigarette Smoking</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Swedish snus ad libitum as a substitute for cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Tobacco-free, nicotine-free placebo snus ad libitum as a substitute for cigarettes</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Swedish snus (smokeless tobacco)</intervention_name>
    <description>Snus in sachets 1.0 g or 0.5 g, 2 flavors. Usage ad libitum.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Onico</intervention_name>
    <description>Tobacco-free, nicotine-free placebo snus, 2 sachet sizes (1.0 g, 0.5 g), 2 flavors (same as in the experimental arm). Usage ad libitum.</description>
    <arm_group_label>2</arm_group_label>
    <other_name>Onico (brand name)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female smokers in good general health aged 20-65 years regularly smoking &gt;10
             cigarettes per day for more than 1 year who are motivated to reduce or quit smoking

        Exclusion Criteria:

          -  Subjects with uncontrolled hypertension, history of coronary heart disease or other
             significant heart condition

          -  History of other significant medical condition that might interfere with study
             procedures

          -  Pregnant or nursing mother

          -  Current drug abuse.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gordana Joksic, Ph D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute for Nuclear Research &quot;Vinca&quot;, Belgrade, Serbia</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Nilsson, Ph D, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Stockholm University, Stockholm, Sweden</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of Nuclear Sciences &quot;Vinca&quot;</name>
      <address>
        <city>Belgrade</city>
        <zip>11001</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ambulanta Medicine Rada, Nis-Jugopetrol</name>
      <address>
        <city>Novi Beograd</city>
        <zip>110 70</zip>
        <country>Serbia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Serbia</country>
  </location_countries>
  <removed_countries>
    <country>Former Serbia and Montenegro</country>
  </removed_countries>
  <results_reference>
    <citation>Joksić G, Spasojević-Tišma V, Antić R, Nilsson R, Rutqvist LE. Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation. Harm Reduct J. 2011 Sep 13;8:25. doi: 10.1186/1477-7517-8-25.</citation>
    <PMID>21914165</PMID>
  </results_reference>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2007</study_first_submitted>
  <study_first_submitted_qc>January 24, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 25, 2008</study_first_posted>
  <last_update_submitted>December 10, 2013</last_update_submitted>
  <last_update_submitted_qc>December 10, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 11, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>smoking reduction</keyword>
  <keyword>smoking cessation</keyword>
  <keyword>randomized trial</keyword>
  <keyword>Swedish snus</keyword>
  <keyword>smokeless tobacco</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lobeline</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

